HERON THERAPEUTICS, INC. /DE/ Quarterly Entity Common Stock, Shares Outstanding from Q2 2011 to Q3 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Heron Therapeutics, Inc. /De/ quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q2 2011 to Q3 2024.
  • Heron Therapeutics, Inc. /De/ Entity Common Stock, Shares Outstanding for the quarter ending November 7, 2024 was 152M shares, a 1.35% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 152M +2.02M +1.35% Nov 7, 2024 10-Q 2024-11-12
Q2 2024 152M +10.9M +7.75% Aug 1, 2024 10-Q 2024-08-06
Q1 2024 151M +31.4M +26.3% May 2, 2024 10-Q 2024-05-07
Q3 2023 150M +31.2M +26.2% Nov 8, 2023 10-Q 2023-11-14
Q2 2023 141M +38.1M +37.1% Jul 25, 2023 10-Q 2023-08-14
Q1 2023 119M +16.8M +16.4% Mar 14, 2023 10-K 2023-03-29
Q3 2022 119M +17M +16.6% Nov 1, 2022 10-Q 2022-11-08
Q2 2022 103M +723K +0.71% Aug 1, 2022 10-Q 2022-08-09
Q1 2022 102M +651K +0.64% May 3, 2022 10-Q 2022-05-09
Q4 2021 102M +10.7M +11.8% Feb 4, 2022 10-K 2022-02-28
Q3 2021 102M +11.1M +12.2% Oct 28, 2021 10-Q 2021-11-03
Q2 2021 102M +11.1M +12.2% Jul 29, 2021 10-Q 2021-08-09
Q1 2021 102M +11.2M +12.3% May 4, 2021 10-Q 2021-05-10
Q4 2020 91.4M +1.02M +1.13% Feb 5, 2021 10-K 2021-02-24
Q3 2020 90.9M +804K +0.89% Oct 29, 2020 10-Q 2020-11-05
Q2 2020 90.9M +11M +13.8% Jul 29, 2020 10-Q 2020-08-05
Q1 2020 90.6M +11.6M +14.6% Apr 29, 2020 10-Q 2020-05-06
Q4 2019 90.4M +12.2M +15.6% Feb 3, 2020 10-K 2020-03-02
Q3 2019 90.1M +12M +15.4% Oct 30, 2019 10-Q 2019-11-12
Q2 2019 79.8M +2.08M +2.68% Jul 17, 2019 10-Q 2019-08-05
Q1 2019 79.1M +7.12M +9.89% Apr 18, 2019 10-Q 2019-05-09
Q4 2018 78.2M +13.5M +20.9% Feb 1, 2019 10-K 2019-02-22
Q3 2018 78M +23.5M +43.1% Oct 26, 2018 10-Q 2018-11-07
Q2 2018 77.7M +23.6M +43.6% Jul 24, 2018 10-Q 2018-08-08
Q1 2018 72M +18.3M +34% Apr 25, 2018 10-Q 2018-05-10
Q4 2017 64.6M +11.1M +20.7% Feb 1, 2018 10-K 2018-02-27
Q3 2017 54.5M +15.3M +39.1% Oct 25, 2017 10-Q 2017-11-06
Q2 2017 54.1M +15.1M +38.6% Jul 26, 2017 10-Q 2017-08-09
Q1 2017 53.7M +17M +46.5% Apr 17, 2017 10-Q 2017-05-10
Q4 2016 53.6M +17.3M +47.9% Feb 3, 2017 10-K 2017-02-23
Q3 2016 39.2M +3.22M +8.94% Oct 27, 2016 10-Q 2016-11-08
Q2 2016 39.1M +3.36M +9.43% Jul 29, 2016 10-Q 2016-08-08
Q1 2016 36.7M +7.03M +23.7% Apr 26, 2016 10-Q 2016-05-05
Q4 2015 36.2M Feb 4, 2016 10-K 2016-02-19
Q3 2015 36M +6.79M +23.3% Oct 26, 2015 10-Q 2015-11-06
Q2 2015 35.7M +6.78M +23.4% Jul 23, 2015 10-Q 2015-08-07
Q1 2015 29.6M +5.73M +24% Apr 28, 2015 10-Q 2015-05-08
Q3 2014 29.2M -284M -90.7% Oct 29, 2014 10-Q 2014-11-06
Q2 2014 28.9M -278M -90.6% Jul 29, 2014 10-Q 2014-08-04
Q1 2014 23.9M -282M -92.2% Apr 28, 2014 10-Q 2014-05-12
Q3 2013 314M +11.4M +3.78% Oct 31, 2013 10-Q 2013-11-12
Q2 2013 307M +4.76M +1.58% Jul 31, 2013 10-Q 2013-08-08
Q1 2013 306M +106M +52.8% Apr 30, 2013 10-Q 2013-05-10
Q3 2012 302M +102M +51.1% Oct 31, 2012 10-Q 2012-11-05
Q2 2012 302M +102M +51.1% Jul 31, 2012 10-Q 2012-08-09
Q1 2012 200M Apr 30, 2012 10-Q 2012-05-10
Q3 2011 200M Oct 31, 2011 10-Q 2011-11-07
Q2 2011 200M Jul 31, 2011 10-Q 2011-08-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.